arsenic trioxide has been researched along with chrysin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aller, P; Ramos, AM | 1 |
Appel, D; Gülden, M; Seibert, H; Syska, M; Uecker, S; Wages, F | 1 |
2 other study(ies) available for arsenic trioxide and chrysin
Article | Year |
---|---|
Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Cell Line, Tumor; Drug Synergism; Flavonoids; Glutathione; Humans; Leukemia; Membrane Potential, Mitochondrial; Oxides; Protein Kinases; Quercetin | 2008 |
Chrysin and silibinin sensitize human glioblastoma cells for arsenic trioxide.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP-Binding Cassette Transporters; Cell Line, Tumor; Flavonoids; Glioblastoma; Humans; Oxides; Silybin; Silymarin | 2017 |